Nouveau traitement pour le traitement de l'hépatite D autorisé aux Etats-Unis

Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection

Eiger BioPharmaceuticals Announces Notice of Allowance for U.S. Patent Covering a Broad Range of Ritonavir-Boosted Lonafarnib Dosing Regimens for Treatment of Hepatitis Delta Virus Infection PALO ...

http://www.eigerbio.com/eiger-biopharmaceuticals-announces-notice-of-allowance-for-u-s-patent-covering-a-broad-range-of-ritonavir-boosted-lonafarnib-dosing-regimens-for-treatment-of-hepatitis-delta-virus-infection/